Bridgeway Capital Management’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Bridgeway Capital Management’s Portfolio NEXI Stock Details NEXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,000	Closed	-$10K	–	1433
2023 Q3	$10K	Hold	2,000	–	–	﹤0.01%	1356
2023 Q2	$13.9K	Hold	2,000	–	–	﹤0.01%	1368
2023 Q1	$19K	Hold	2,000	–	–	﹤0.01%	1358
2022 Q4	$12.2K	Hold	2,000	–	–	﹤0.01%	1357
2022 Q3	$28K	Hold	2,000	–	–	﹤0.01%	1380
2022 Q2	$81K	Hold	2,000	–	–	﹤0.01%	1251
2022 Q1	$211K	Buy	+2,000	New	+$147K	﹤0.01%	1162

Other funds holding NEXI

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bridgeway Capital Management's NEXI Position: Q4 2023 in Review

Bridgeway Capital Management sold out of NexImmune, Inc. Common Stock (NEXI) in Q4 2023, closing a stake of 2,000 shares — an estimated $10K sold.

Bridgeway Capital Management first reported a position in NEXI in Q1 2022 and held it in 7 quarters. The position peaked at $211K in Q1 2022. 11 funds tracked by Wall St. Rank hold NEXI as of Q4 2023.

Bridgeway Capital Management reported no remaining NexImmune, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Bridgeway Capital Management sold 2,000 NexImmune, Inc. Common Stock shares in Q4 2023, an estimated $10K.
Bridgeway Capital Management first reported a position in NexImmune, Inc. Common Stock in Q1 2022 and held it in 7 quarters.
Bridgeway Capital Management's NexImmune, Inc. Common Stock position peaked at $211K in Q1 2022.
11 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q4 2023.

Based on Bridgeway Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.